Compare Stocks: BIOR, XRTX, SPRC, and GLMD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIOR Biora Therapeutics	$0.22	$0.14	$0.15 ▼ $7.10	$995K	1.12	86,634 shs	N/A
GLMD Galmed Pharmaceuticals	$0.60	$0.58	$0.41 ▼ $1.65	$3.97M	0.74	960,714 shs	21,890 shs
SPRC SciSparc	$6.93	$6.78	$2.98 ▼ $80.10	$3.92M	2.78	474,894 shs	13,860 shs
XRTX XORTX Therapeutics	$2.13	$2.11	$1.73 ▼ $7.05	$3.88M	0.73	15,566 shs	4,548 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIOR Biora Therapeutics	0.00%	0.00%	0.00%	0.00%	+50.79%
GLMD Galmed Pharmaceuticals	0.00%	-3.08%	+7.48%	+3.70%	-58.49%
SPRC SciSparc	0.00%	-2.67%	+47.45%	+14.36%	-85.16%
XRTX XORTX Therapeutics	0.00%	+0.47%	+1.43%	-13.41%	-46.42%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIOR Biora Therapeutics	$0.22	$0.14	$0.15 ▼ $7.10	$995K	1.12	86,634 shs	N/A
GLMD Galmed Pharmaceuticals	$0.60	$0.58	$0.41 ▼ $1.65	$3.97M	0.74	960,714 shs	21,890 shs
SPRC SciSparc	$6.93	$6.78	$2.98 ▼ $80.10	$3.92M	2.78	474,894 shs	13,860 shs
XRTX XORTX Therapeutics	$2.13	$2.11	$1.73 ▼ $7.05	$3.88M	0.73	15,566 shs	4,548 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIOR Biora Therapeutics	0.00%	0.00%	0.00%	0.00%	+50.79%
GLMD Galmed Pharmaceuticals	0.00%	-3.08%	+7.48%	+3.70%	-58.49%
SPRC SciSparc	0.00%	-2.67%	+47.45%	+14.36%	-85.16%
XRTX XORTX Therapeutics	0.00%	+0.47%	+1.43%	-13.41%	-46.42%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIOR Biora Therapeutics	0.00	N/A	N/A	N/A
GLMD Galmed Pharmaceuticals	1.00	Sell	N/A	N/A
SPRC SciSparc	1.00	Sell	N/A	N/A
XRTX XORTX Therapeutics	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest BIOR, XRTX, SPRC, and GLMD Analyst Ratings

Date	Company	Brokerage	Action	Rating
7/17/2026	GLMD Galmed Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/24/2026	XRTX XORTX Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
5/26/2026	SPRC SciSparc	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 8/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIOR Biora Therapeutics	$892K	1.12	N/A	N/A	($36.43) per share	-0.01
GLMD Galmed Pharmaceuticals	N/A	N/A	N/A	N/A	$2.88 per share	N/A
SPRC SciSparc	$856K	4.58	N/A	N/A	$12.93 per share	0.54
XRTX XORTX Therapeutics	N/A	N/A	N/A	N/A	$1.50 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIOR Biora Therapeutics	-$124.11M	-$13.04	N/A	N/A	N/A	N/A	N/A	-332.47%	N/A
GLMD Galmed Pharmaceuticals	-$10.31M	-$0.91	N/A	N/A	N/A	N/A	-35.32%	-30.94%	8/10/2026 (Estimated)
SPRC SciSparc	-$12.18M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
XRTX XORTX Therapeutics	-$2.66M	-$2.63	N/A	N/A	N/A	N/A	-150.01%	-106.53%	8/13/2026 (Estimated)

Latest BIOR, XRTX, SPRC, and GLMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/10/2026	N/A	GLMD Galmed Pharmaceuticals	-$0.39	N/A	N/A	N/A	N/A	N/A
5/16/2026	Q1 2026	XRTX XORTX Therapeutics	N/A	-$0.58	N/A	-$0.58	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIOR Biora Therapeutics	N/A	N/A	N/A	N/A	N/A
GLMD Galmed Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
SPRC SciSparc	N/A	N/A	N/A	N/A	N/A
XRTX XORTX Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIOR Biora Therapeutics	N/A	0.05	0.05
GLMD Galmed Pharmaceuticals	N/A	7.71	7.71
SPRC SciSparc	N/A	2.41	2.38
XRTX XORTX Therapeutics	N/A	0.86	0.86

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIOR Biora Therapeutics	43.74%
GLMD Galmed Pharmaceuticals	76.14%
SPRC SciSparc	25.06%
XRTX XORTX Therapeutics	0.23%

Insider Ownership

Company	Insider Ownership
BIOR Biora Therapeutics	51.08%
GLMD Galmed Pharmaceuticals	19.80%
SPRC SciSparc	1.52%
XRTX XORTX Therapeutics	6.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIOR Biora Therapeutics	120	4.52 million	2.21 million	No Data
GLMD Galmed Pharmaceuticals	20	6.60 million	5.29 million	Not Optionable
SPRC SciSparc	4	566,000	557,000	Not Optionable
XRTX XORTX Therapeutics	N/A	1.82 million	1.69 million	Not Optionable

BIOR, XRTX, SPRC, and GLMD Headlines

Recent News About These Companies

XORTX Therapeutics Announces Resignation of Board Chairman Anthony Giovinazzo

August 4, 2026 | tipranks.com

XORTX Therapeutics Inc. annonce la démission d'Anthony Giovinazzo de son poste d'administrateur

August 2, 2026 | zonebourse.comZ

XORTX Therapeutics Inc.: XORTX Announces Director Resignation

August 1, 2026 | finanznachrichten.de

XORTX Announces Director Resignation

July 31, 2026 | financialpost.comF

XORTX Announces Director Resignation

July 31, 2026 | globenewswire.com

XORTX Therapeutics Adds Independent Director to Strengthen Board Oversight

July 29, 2026 | tipranks.com

XORTX Appoints New Director

July 29, 2026 | financialpost.comF

XORTX Appoints New Director

July 29, 2026 | globenewswire.com

XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO

June 15, 2026 | financialpost.comF

XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO

June 15, 2026 | globenewswire.com

XORTX to Voluntarily Delist from TSX Venture Exchange, Maintain Nasdaq Listing

June 12, 2026 | tipranks.com

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

June 12, 2026 | financialpost.comF

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

June 12, 2026 | globenewswire.com

XORTX Announces Closing of US$5 Million Public Offering

May 19, 2026 | financialpost.comF

XORTX Announces Closing of US$5 Million Public Offering

May 19, 2026 | globenewswire.com

XORTX files Q1 2026 unaudited results showing lower cash and equity

May 19, 2026 | tipranks.com

E.F. Hutton & Co. Serves as Exclusive Placement Agent on XORTX Therapeutics Inc. $5 Million Public Offering

May 18, 2026 | globenewswire.com

XORTX Therapeutics Prices US$5 Million Public Offering to Fund Late-Stage Kidney and Gout Pipeline

May 14, 2026 | tipranks.com

XORTX Announces US$5 Million Public Offering

May 14, 2026 | financialpost.comF

XORTX Announces US$5 Million Public Offering

May 14, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOR, XRTX, SPRC, and GLMD Company Descriptions

Biora Therapeutics NASDAQ:BIOR

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Galmed Pharmaceuticals NASDAQ:GLMD

$0.60 0.00 (0.00%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$0.60 0.00 (-0.15%)

As of 08/7/2026 06:16 PM Eastern

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Tel Aviv, Israel.

SciSparc NASDAQ:SPRC

$6.93 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$6.92 -0.01 (-0.22%)

As of 08/7/2026 07:34 PM Eastern

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

XORTX Therapeutics NASDAQ:XRTX

$2.13 0.00 (0.00%)

Closing price 08/7/2026 03:57 PM Eastern

Extended Trading

$2.13 0.00 (0.00%)

As of 08/7/2026 07:34 PM Eastern

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BIOR, XRTX, SPRC, and GLMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BIOR, XRTX, SPRC, and GLMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BIOR, XRTX, SPRC, and GLMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOR, XRTX, SPRC, and GLMD Company Descriptions

Biora Therapeutics NASDAQ:BIOR

Galmed Pharmaceuticals NASDAQ:GLMD

SciSparc NASDAQ:SPRC

XORTX Therapeutics NASDAQ:XRTX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BIOR, XRTX, SPRC, and GLMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BIOR, XRTX, SPRC, and GLMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BIOR, XRTX, SPRC, and GLMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOR, XRTX, SPRC, and GLMD Company Descriptions

Biora Therapeutics NASDAQ:BIOR

Galmed Pharmaceuticals NASDAQ:GLMD

SciSparc NASDAQ:SPRC

XORTX Therapeutics NASDAQ:XRTX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools